The vision of the UNITWIN network to support improvement in pharmacy education in Africa and a decade of experience forms the basis of this webinar where the AcPS joins the FIP Provisions & Programme Lead and UNITWIN & Provision manager in discussion with FIP-UNESCO UNITWIN CfE Africas founding member, Prof Cyril Usifoh, and AcPS and CfEA member, Prof Arinola Joda to learn from a decade of their experience at the CfE to address inequities and standardise pharmacy education across Africa towards strategies to enable the same across other WHO regions.

Moderator:
-Mansi Doshi, FIP AcPS Collaboration and Communication Lead; Co-Chair, FIP-UNESCO UNITWIN CfE SEAR; Medicines Optimisation Consultant & Adjunct Faculty, India

Co-Moderator & Facilitator:
- Ms Evrim Çakıl, Community pharmacist, Türkiye
- Ms Venkata Komali Medam, National President, The Indian Pharmaceutical Association-Students’ Forum (IPA-SF), 2025-26, India

Panelists:
- Prof Cyril Usifoh, Professor of Pharmaceutical Chemistry, University of Benin, Edo State, Nigeria
- Prof Arinola Joda, Professor of Clinical Pharmacy, University of Lagos, Nigeria
- Dr Genuine Desireh, UNITWIN and Provision Manager, FIP, The Netherlands
- Mansi Doshi, FIP AcPS Collaboration and Communication Lead; Co-Chair, FIP-UNESCO UNITWIN CfE SEAR; Medicines Optimisation Consultant & Adjunct Faculty, India
- Prof Dr Chun-Wai Mai, Deputy Director, Research, Strategy and Impact, IMU University, Malaysia

The results of an AcPS Working Group #4 project revealed that pharmacists interested in an academic career or very new faculty members needed very basic skills in research fundamentals. Evidence indicated this special need for tailored career development pathways and resources for pharmacists considering academic careers, as well as for early-career educators seeking to expand their professional trajectories. This first Webinar in the series is designed to introduce participants to the very beginning of research methods. The session also includes an application research tool that participants can use.

Moderator:

-Dr. Mohamed Elnaem, lecturer in Clinical Pharmacy and Chair of the Global PharmEd Optimise Research (GPOR) network at Ulster University/Lead of the Research and Scholarship Working Group – Academic Pharmacy Section – FIP, Ulster University, United Kingdom.

Co-moderator/Chair:

-Dr. Barry A. Bleidt, Adjunct Professor - Florida A&M University College of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University.

Panelists:

-Prof. Miray Arslan, Job Title Professor of Pharmacy Management , Organization/Institution Van Yüzüncü Yıl University, Faculty of Pharmacy, Department of Pharmacy Management , Türkiye.
-Dr. Norman E. Fenn, III, Job Title Clinical Associate Professor, Manchester University College of Health Professions, Nursing, & Pharmacy, USA.
-Dr. Yaa Osei, Registered pharmacist and Senior Lecturer in the Department of Pharmaceutics at Kwame Nkrumah University of Science and Technology, Ghana.
-Dr. Suhaib Muflih, Associate Professor, Organization/Institution Imam Abdulrahman Bin Faisal University; Jordan University of Science and Technology, Saudi Arabia.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

Adeno-associated virus (AAV), a non-pathogenic single-stranded DNA virus that transduces both dividing and non-dividing cells, has emerged as a leading gene therapy platform. It persists primarily as an episode with a low insertional mutagenesis risk and elicits a comparatively mild
immune response. Eleven AAV-based therapies have been approved by the FDA Yet significant challenges limit how far the platform can go. Pre-existing neutralizing antibodies and treatment-induced immunogenicity restricts eligibility and blocks re-dosing, native packaging capacity is limited to ~4.7 kb, production still suffers from low yield and high empty-to-full capsid ratios, and finished products require stable formulations that needs to withstand ultra-low-temperature (≤ -60°C) storage, and controlled freeze-thaw without loss of potency. This presentation will discuss AAV's basic biology and structure, capsid engineering, manufacturing, purification, and
formulation advances and approaches to overcome these limitations.

Chair:
-Dr. Mathew Cherian PhD, FIP, USA.

Co-moderator:
Dr. Richard Ohene-Darkoh, Pharmaceutical Country Manager, Liberia.

Panellists:
-Dr. Subhro Guhathakurta PhD, Review Editor Frontiers in Molecular Neuroscience, USA.
-Dr. Sandeep Nema PhD, Ironwood Pharmaceuticals, USA.

*Please note that a Zoom account is required to register for this FIP Digital Event. If you are receiving an error message during registration, please create a Zoom account and use the corresponding email address for your registration.

The Journal of Pharmaceutical Policy and Practice (JoPPP) was established in 2008 with the mission to promote pharmaceutical policy and practice globally. The journal is published in the United Kingdom, indexed in Scopus and PubMed Central, and managed by a distinguished international editorial board. Based on its growing body of research articles, presentations, and best practices, JoPPP will hold the “5th JOPPP IMPACT MONGOLIA - 2026” conference in collaboration with Etugen University on November 11–13, 2026.

Join us for the world’s first LGBTQIA+-focused pharmacy conference, proudly endorsed by the International Pharmaceutical Federation (FIP). This landmark three-day event brings together LGBTQIA+ pharmacists, students, educators, researchers and allies to build a more inclusive and culturally safe future for pharmacy practice.